Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next
November 01, 2016 at 07:52 AM EDT
We are almost through the earnings season and despite good results most biotech stocks are tanking. Stocks taking the biggest hits in October were: Amgen down 14.74%, Regeneron down 14%, Vertex down 12.3%, Abbvie down 11.4% and Biogen down 10.35%.